{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T18:09:13Z","timestamp":1773511753938,"version":"3.50.1"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["F32DK130288"],"award-info":[{"award-number":["F32DK130288"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K01DK123195"],"award-info":[{"award-number":["K01DK123195"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K01DK121869"],"award-info":[{"award-number":["K01DK121869"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30 DK123704"],"award-info":[{"award-number":["P30 DK123704"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20 GM120457"],"award-info":[{"award-number":["P20 GM120457"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Carcinoma of the endometrium of the uterus is the most common female pelvic malignancy. Although uterine corpus endometrial cancer (UCEC) has a favorable prognosis if removed early, patients with advanced tumor stages have a low survival rate. These facts highlight the importance of understanding UCEC biology. Computational analysis of RNA-sequencing data from UCEC patients revealed that the molecular motor Myosin Vb (MYO5B) was elevated in the beginning stages of UCEC and occurred in all patients regardless of tumor stage, tumor type, age, menopause status or ethnicity. Although several mutations were identified in the MYO5B gene in UCEC patients, these mutations did not correlate with mRNA expression. Examination of MYO5B methylation revealed that UCEC patients had undermethylated MYO5B and undermethylation was positively correlated with increased mRNA and protein levels. Immunostaining confirmed elevated levels of apical MYO5B in UCEC patients compared to adjacent tissue. UCEC patients with high expressing MYO5B tumors had far worse prognosis than UCEC patients with low expressing MYO5B tumors, as reflected by survival curves. Metabolic pathway analysis revealed significant alterations in metabolism pathways in UCE patients and key metabolism genes were positively correlated with MYO5B mRNA. These data provide the first evidence that MYO5B may participate in UCEC tumor development.<\/jats:p>","DOI":"10.1371\/journal.pone.0280428","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T18:37:27Z","timestamp":1674239847000},"page":"e0280428","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bioinformatics reveal elevated levels of Myosin Vb in uterine corpus endometrial carcinoma patients which correlates to increased cell metabolism and poor prognosis"],"prefix":"10.1371","volume":"18","author":[{"given":"Kristen A.","family":"Engevik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9742-9932","authenticated-orcid":true,"given":"Melinda A.","family":"Engevik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy C.","family":"Engevik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,1,20]]},"reference":[{"issue":"5","key":"pone.0280428.ref001","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"J Ferlay","year":"2015","journal-title":"Int J Cancer"},{"issue":"10","key":"pone.0280428.ref002","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1634\/theoncologist.2010-0087","article-title":"Endometrial Carcinoma: A Review of Chemotherapy, Drug Resistance, and the Search for New Agents.","volume":"15","author":"KM Moxley","year":"2010","journal-title":"The Oncologist."},{"key":"pone.0280428.ref003","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.2147\/CMAR.S290467","article-title":"USP5 Promotes Uterine Corpus Endometrial Carcinoma Cell Growth and Migration via mTOR\/4EBP1 Activation.","volume":"13","author":"Y Li","year":"2021","journal-title":"Cancer Manag Res."},{"issue":"1","key":"pone.0280428.ref004","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018.","volume":"68","author":"RL Siegel","year":"2018","journal-title":"CA Cancer J Clin."},{"key":"pone.0280428.ref005","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.omto.2021.07.002","article-title":"Development of a seven-gene tumor immune microenvironment prognostic signature for high-risk grade III endometrial cancer","volume":"22","author":"M Zheng","year":"2021","journal-title":"Molecular Therapy\u2014Oncolytics"},{"issue":"6","key":"pone.0280428.ref006","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"J Ferlay","year":"2013","journal-title":"Eur J Cancer"},{"key":"pone.0280428.ref007","first-page":"95","article-title":"Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.","volume":"1","author":"WT Creasman","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"pone.0280428.ref008","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ygyno.2011.11.049","article-title":"Do uterine risk factors or lymph node metastasis more significantly affect recurrence in patients with endometrioid adenocarcinoma?","volume":"125","author":"EK Nugent","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"11","key":"pone.0280428.ref009","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1038\/bjc.2014.237","article-title":"A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion","volume":"110","author":"S Bendifallah","year":"2014","journal-title":"Br J Cancer"},{"issue":"5","key":"pone.0280428.ref010","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/bjc.2015.35","article-title":"Just how accurate are the major risk stratification systems for early-stage endometrial cancer?","volume":"112","author":"S Bendifallah","year":"2015","journal-title":"Br J Cancer"},{"issue":"2","key":"pone.0280428.ref011","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1677\/ERC-08-0266","article-title":"Resistance to chemotherapy and hormone therapy in endometrial cancer","volume":"16","author":"P Chaudhry","year":"2009","journal-title":"Endocr Relat Cancer"},{"issue":"10","key":"pone.0280428.ref012","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11101562","article-title":"A Pan-Cancer Approach to Predict Responsiveness to Immune Checkpoint Inhibitors by Machine Learning.","volume":"11","author":"M Polano","year":"2019","journal-title":"Cancers (Basel)."},{"issue":"3","key":"pone.0280428.ref013","first-page":"2464","article-title":"Identification of key genes and pathways between type I and type II endometrial cancer using bioinformatics analysis","volume":"18","author":"K Zhang","year":"2019","journal-title":"Oncol Lett"},{"issue":"8","key":"pone.0280428.ref014","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1053\/j.gastro.2020.02.034","article-title":"Editing Myosin VB Gene to Create Porcine Model of Microvillus Inclusion Disease, With Microvillus-Lined Inclusions and Alterations in Sodium Transporters","volume":"158","author":"AC Engevik","year":"2020","journal-title":"Gastroenterology"},{"issue":"11","key":"pone.0280428.ref015","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1083\/jcb.201902063","article-title":"Loss of myosin Vb promotes apical bulk endocytosis in neonatal enterocytes","volume":"218","author":"AC Engevik","year":"2019","journal-title":"J Cell Biol"},{"issue":"6","key":"pone.0280428.ref016","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1053\/j.gastro.2018.08.025","article-title":"Loss of MYO5B Leads to Reductions in Na(+) Absorption With Maintenance of CFTR-Dependent Cl(-) Secretion in Enterocytes.","volume":"155","author":"AC Engevik","year":"2018","journal-title":"Gastroenterology"},{"issue":"4","key":"pone.0280428.ref017","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1053\/j.gastro.2020.06.008","article-title":"Lysophosphatidic Acid Increases Maturation of Brush Borders and SGLT1 Activity in MYO5B-deficient Mice, a Model of Microvillus Inclusion Disease","volume":"159","author":"I Kaji","year":"2020","journal-title":"Gastroenterology"},{"key":"pone.0280428.ref018","first-page":"8","article-title":"Intracellular Transport in Cancer Metabolic Reprogramming.","author":"M Sneeggen","year":"2020","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"12","key":"pone.0280428.ref019","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/cam4.4608","article-title":"Spatiotemporal trends in burden of uterine cancer and its attribution to body mass index in 204 countries and territories from 1990 to 2019.","volume":"11","author":"S Li","year":"2022","journal-title":"Cancer Med."},{"issue":"1","key":"pone.0280428.ref020","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1038\/s41467-019-13528-0","article-title":"Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers","volume":"10","author":"F Chen","year":"2019","journal-title":"Nature Communications"},{"issue":"5","key":"pone.0280428.ref021","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052622","article-title":"TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues.","volume":"22","author":"\u00c1 Bartha","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"D1","key":"pone.0280428.ref022","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the Catalogue Of Somatic Mutations In Cancer","volume":"47","author":"JG Tate","year":"2018","journal-title":"Nucleic Acids Research"},{"issue":"W1","key":"pone.0280428.ref023","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"T Li","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"269","key":"pone.0280428.ref024","first-page":"pl1","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"J Gao","year":"2013","journal-title":"Sci Signal"},{"issue":"5","key":"pone.0280428.ref025","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"E Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"1","key":"pone.0280428.ref026","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1186\/s12864-015-1847-z","article-title":"MEXPRESS: visualizing expression, DNA methylation and clinical TCGA data","volume":"16","author":"A Koch","year":"2015","journal-title":"BMC Genomics"},{"issue":"W1","key":"pone.0280428.ref027","doi-asserted-by":"crossref","first-page":"W561","DOI":"10.1093\/nar\/gkz445","article-title":"MEXPRESS update 2019","volume":"47","author":"A Koch","year":"2019","journal-title":"Nucleic Acids Research"},{"issue":"21","key":"pone.0280428.ref028","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells","volume":"77","author":"T Li","year":"2017","journal-title":"Cancer Res"},{"issue":"1","key":"pone.0280428.ref029","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","article-title":"Comprehensive analyses of tumor immunity: implications for cancer immunotherapy","volume":"17","author":"B Li","year":"2016","journal-title":"Genome Biol"},{"issue":"D1","key":"pone.0280428.ref030","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"D Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"21","key":"pone.0280428.ref031","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1093\/bioinformatics\/bty411","article-title":"GSCALite: a web server for gene set cancer analysis","volume":"34","author":"C-J Liu","year":"2018","journal-title":"Bioinformatics"},{"issue":"D1","key":"pone.0280428.ref032","doi-asserted-by":"crossref","first-page":"D959","DOI":"10.1093\/nar\/gkv1128","article-title":"ccmGDB: a database for cancer cell metabolism genes","volume":"44","author":"P Kim","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"pone.0280428.ref033","doi-asserted-by":"crossref","first-page":"e1008803","DOI":"10.1371\/journal.pgen.1008803","article-title":"MYO5B mutations in pheochromocytoma\/paraganglioma promote cancer progression","volume":"16","author":"TT Tomi\u0107","year":"2020","journal-title":"PLoS Genet"},{"issue":"9","key":"pone.0280428.ref034","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/ijc.29957","article-title":"Malignant pheochromocytomas\/paragangliomas harbor mutations in transport and cell adhesion genes","volume":"138","author":"A Wilzen","year":"2016","journal-title":"Int J Cancer"},{"issue":"8","key":"pone.0280428.ref035","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/leu.2008.130","article-title":"Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia","volume":"22","author":"SQ Kuang","year":"2008","journal-title":"Leukemia"},{"issue":"7","key":"pone.0280428.ref036","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1007\/s10620-013-2600-6","article-title":"MYO5B is epigenetically silenced and associated with MET signaling in human gastric cancer","volume":"58","author":"W Dong","year":"2013","journal-title":"Dig Dis Sci"},{"issue":"11","key":"pone.0280428.ref037","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/bjc.2017.352","article-title":"Loss of Myosin Vb in colorectal cancer is a strong prognostic factor for disease recurrence","volume":"117","author":"E Letellier","year":"2017","journal-title":"British Journal of Cancer"},{"key":"pone.0280428.ref038","article-title":"Rab GTPases: Central Coordinators of Membrane Trafficking in Cancer.","volume":"9","author":"H Jin","year":"2021","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"8","key":"pone.0280428.ref039","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrm2728","article-title":"Rab GTPases as coordinators of vesicle traffic","volume":"10","author":"H. Stenmark","year":"2009","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"1","key":"pone.0280428.ref040","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12929-016-0287-7","article-title":"Rab-mediated vesicle trafficking in cancer","volume":"23","author":"HT Tzeng","year":"2016","journal-title":"J Biomed Sci"},{"issue":"5","key":"pone.0280428.ref041","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"D Hanahan","year":"2011","journal-title":"Cell"},{"issue":"6487","key":"pone.0280428.ref042","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"B Faubert","year":"2020","journal-title":"Science"},{"key":"pone.0280428.ref043","article-title":"Immune and Metabolic Dysregulated Coding and Non-coding RNAs Reveal Survival Association in Uterine Corpus Endometrial Carcinoma.","volume":"12","author":"D Liu","year":"2021","journal-title":"Frontiers in Genetics"},{"issue":"1","key":"pone.0280428.ref044","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-pathol-020117-043609","article-title":"Molecular Genetics of Endometrial Carcinoma. Annual Review of Pathology","volume":"14","author":"DW Bell","year":"2019","journal-title":"Mechanisms of Disease"},{"issue":"1","key":"pone.0280428.ref045","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1186\/s12935-021-02215-0","article-title":"Identification of the prognostic value of a 2-gene signature of the WNT gene family in UCEC using bioinformatics and real-world data","volume":"21","author":"Y Hu","year":"2021","journal-title":"Cancer Cell International"},{"issue":"3","key":"pone.0280428.ref046","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.3892\/ol.2020.11798","article-title":"Identification of a five-gene signature for predicting the progression and prognosis of stage I endometrial carcinoma.","volume":"20","author":"J Bian","year":"2020","journal-title":"Oncol Lett."},{"issue":"3","key":"pone.0280428.ref047","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2021.32.e30","article-title":"Identification of an immune-related risk signature and nomogram predicting the overall survival in patients with endometrial cancer","volume":"32","author":"Y Cheng","year":"2021","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"pone.0280428.ref048","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1186\/s12885-020-07535-4","article-title":"An integrated autophagy-related gene signature predicts prognosis in human endometrial Cancer","volume":"20","author":"J Zhang","year":"2020","journal-title":"BMC Cancer"},{"issue":"1","key":"pone.0280428.ref049","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13048-019-0557-6","article-title":"Alteration of tumor associated neutrophils by PIK3CA expression in endometrial carcinoma from TCGA data.","volume":"12","author":"Y Pan","year":"2019","journal-title":"J Ovarian Res"},{"issue":"11","key":"pone.0280428.ref050","doi-asserted-by":"crossref","first-page":"e3000531","DOI":"10.1371\/journal.pbio.3000531","article-title":"Loss of MYO5B expression deregulates late endosome size which hinders mitotic spindle orientation","volume":"17","author":"C Leng","year":"2019","journal-title":"PLoS Biol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0280428","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T18:38:02Z","timestamp":1674239882000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0280428"}},"subtitle":[],"editor":[{"given":"Divijendra Natha Reddy","family":"Sirigiri","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,1,20]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0280428","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,20]]}}}